Prudential Financial’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.3M Buy
200,781
+183,690
+1,075% +$16.5M 0.02% 445
2025
Q4
$1.49M Buy
17,091
+5,270
+45% +$400K ﹤0.01% 1446
2025
Q3
$677K Sell
11,821
-13,390
-53% -$771K ﹤0.01% 1804
2025
Q2
$1.49M Buy
25,211
+415
+2% +$26.8K ﹤0.01% 1506
2025
Q1
$1.82M Buy
24,796
+8,890
+56% +$735K ﹤0.01% 1325
2024
Q4
$1.32M Buy
15,906
+3,637
+30% +$287K ﹤0.01% 1471
2024
Q3
$878K Sell
12,269
-2,861
-19% -$202K ﹤0.01% 1959
2024
Q2
$1.04M Buy
15,130
+3,112
+26% +$186K ﹤0.01% 1816
2024
Q1
$645K Sell
12,018
-791
-6% -$42.5K ﹤0.01% 2060
2023
Q4
$683K Buy
12,809
+1,016
+9% +$49.5K ﹤0.01% 2000
2023
Q3
$586K Buy
11,793
+2,272
+24% +$127K ﹤0.01% 1998
2023
Q2
$550K Sell
9,521
-190
-2% -$10.8K ﹤0.01% 2074
2023
Q1
$561K Sell
9,711
-8,440
-46% -$541K ﹤0.01% 2016
2022
Q4
$1.35M Buy
18,151
+833
+5% +$56.7K ﹤0.01% 1540
2022
Q3
$1.03M Sell
17,318
-1,596
-8% -$96.1K ﹤0.01% 1738
2022
Q2
$1.09M Sell
18,914
-45,020
-70% -$2.96M ﹤0.01% 1748
2022
Q1
$4.72M Sell
63,934
-22,448
-26% -$1.56M 0.01% 1002
2021
Q4
$6.68M Buy
86,382
+24,076
+39% +$1.75M 0.01% 879
2021
Q3
$5.03M Buy
62,306
+13,241
+27% +$1.06M 0.01% 987
2021
Q2
$3.8M Buy
49,065
+27,143
+124% +$1.93M 0.01% 1149
2021
Q1
$1.35M Buy
21,922
+853
+4% +$54K ﹤0.01% 1673
2020
Q4
$1.37M Buy
21,069
+1,605
+8% +$92.3K ﹤0.01% 1602
2020
Q3
$964K Buy
19,464
+2,082
+12% +$107K ﹤0.01% 1664
2020
Q2
$830K Sell
17,382
-215,250
-93% -$10.4M ﹤0.01% 1732
2020
Q1
$9.89M Buy
232,632
+80,614
+53% +$3.98M 0.02% 639
2019
Q4
$8.95M Buy
152,018
+99,526
+190% +$5.4M 0.01% 899
2019
Q3
$2.68M Sell
52,492
-1,537
-3% -$73.2K ﹤0.01% 1429
2019
Q2
$2.29M Buy
54,029
+2,143
+4% +$93.1K ﹤0.01% 1530
2019
Q1
$2.56M Sell
51,886
-3,383
-6% -$153K ﹤0.01% 1482
2018
Q4
$2.39M Sell
55,269
-25,660
-32% -$1.28M ﹤0.01% 1438
2018
Q3
$4.59M Sell
80,929
-193,956
-71% -$10.2M 0.01% 1208
2018
Q2
$13.9M Buy
274,885
+117,379
+75% +$6.12M 0.02% 798
2018
Q1
$7.85M Buy
157,506
+107,486
+215% +$5.05M 0.01% 1010
2017
Q4
$2.06M Buy
50,020
+610
+1% +$21.4K ﹤0.01% 1576
2017
Q3
$1.47M Buy
49,410
+810
+2% +$24.7K ﹤0.01% 1711
2017
Q2
$1.61M Buy
48,600
+3,070
+7% +$96.4K ﹤0.01% 1663
2017
Q1
$1.35M Sell
45,530
-30
-0.1% -$819 ﹤0.01% 1738
2016
Q4
$1.13M Buy
+45,560
New +$1.04M ﹤0.01% 1798
2015
Q4
Sell
-78,800
Closed -$1.63M 2247
2015
Q3
$1.63M Sell
78,800
-20,900
-21% -$529K ﹤0.01% 1553
2015
Q2
$2.56M Sell
99,700
-29,920
-23% -$758K ﹤0.01% 1450
2015
Q1
$3.27M Sell
129,620
-3,900
-3% -$95K 0.01% 1349
2014
Q4
$3.17M Sell
133,520
-38,400
-22% -$850K 0.01% 1225
2014
Q3
$3.38M Sell
171,920
-9,200
-5% -$189K 0.01% 1143
2014
Q2
$4.33M Buy
+181,120
New +$4.37M 0.01% 1082

Other funds holding GMED

Prudential Financial's GMED Position: Q1 2026 in Review

Prudential Financial increased its Globus Medical (GMED) stake by 1,075% in Q1 2026, buying an estimated $16.5M and bringing the position to 200,781 shares worth $17.3M. The position accounts for 0.02% of the portfolio, ranked #445.

Prudential Financial first reported a position in GMED in Q2 2014 and has held it in 44 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Prudential Financial held 200,781 shares of Globus Medical worth $17.3M as of Q1 2026.
  • Prudential Financial bought 183,690 Globus Medical shares in Q1 2026, an estimated $16.5M.
  • Globus Medical made up 0.02% of Prudential Financial's portfolio in Q1 2026, its #445 holding.
  • Prudential Financial first reported a position in Globus Medical in Q2 2014 and has held it in 44 quarters since.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.